Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
about
Genome of horsepox virusThe evolution of poxvirus vaccinesPoxvirus tropismThe inflammasome as a target of modulation by DNA virusesLower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus.Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.Comparison on virulence and immunogenicity of two recombinant vaccinia vaccines, Tian Tan and Guang9 strains, expressing the HIV-1 envelope gene.Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia virusesDeletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in micePreferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-βThe ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responsesB5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.Viruses with deletions in antiapoptotic genes as potential oncolytic agents.Evasion of innate immunity by vaccinia virus.Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design.Vaccinia virus vaccines: past, present and future.Smallpox vaccines for biodefense.IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenicStaying alive: cell death in antiviral immunity.Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus.A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors.Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes.Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
P2860
Q21558569-4E5C9341-E992-4927-9EFE-4AF38F71B3C2Q26995905-67B9890B-3197-4374-BAFE-CAC8CFACEBB0Q28237434-DE4B46D7-EF90-4F61-AF2D-3494EAD00AE3Q28388139-17F834C8-4033-468C-9AEB-D13B394CC818Q30373857-F0F58209-5CA3-40C8-9513-B9A21E97807FQ33780579-FDC65C0C-0906-4E14-8632-6D73E3AD9FF8Q33838507-E5F9A05F-5080-4CCF-A76A-E5112E97B0D8Q33840818-B55B6776-F1C1-4E03-98C3-0E3CCBFE5277Q34120696-D1D2AE73-049A-49B9-8EDB-63E828C90956Q34368703-F57B99BB-FFEE-4CF4-9D15-0335F6D43837Q34471962-192DC9DE-390E-4D3E-B4EC-5B3B3FCAFC6AQ34651266-5E0BE4A1-709E-4CD6-BF5E-D00ED62B7BA8Q34742613-E6834233-B8CC-4031-ABD4-7A6A8980CCC7Q35023470-AE48ADF8-BA32-4456-91A8-B0DA31DDD500Q35076706-B92A8A2F-46C6-4424-A074-3FFBBA6D2A8DQ35202797-045F4FD9-7398-4901-AC31-73F13A4003A7Q35292546-344E7F8C-CDF7-4798-B518-25C33B54BD5EQ35362732-626F67DA-20DC-4C5D-B572-9816F9C1C0A6Q36103012-1E4C94ED-B337-4C2A-B66F-A72F42EA842BQ36254857-4568B568-AB76-4764-8098-8B405F03FF36Q36310934-F591040F-95D8-4D18-BDC3-A75A4BC678D2Q36728801-D6CF2363-BCCE-4C97-886C-836BBA475287Q37343595-6DAE90F6-85DE-4FBC-8ABE-4E72E7E760CAQ37393765-CC301092-2F57-4823-BE7E-2ACFF1FEAB47Q37617613-CDD3F5F9-DAB0-4DD7-A1E9-F3C21A1403ACQ38207187-53BCEE9B-7CB9-402E-B6A2-52C0524EC87DQ39706186-5C99DE7B-7C81-48DE-9557-75138BC3428CQ40452852-5B1AD444-D213-48C7-BAF6-92D81DEA1E08Q45324442-099327CC-8611-458A-A4F1-5E80684F3B66Q45325191-2B576FF9-DFC2-429F-9D4B-1866FE2E028DQ45325213-D60DC089-AB29-4202-BD65-F9EA5319DF4E
P2860
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Induction of potent humoral an ...... ors with deleted serpin genes.
@ast
Induction of potent humoral an ...... ors with deleted serpin genes.
@en
type
label
Induction of potent humoral an ...... ors with deleted serpin genes.
@ast
Induction of potent humoral an ...... ors with deleted serpin genes.
@en
prefLabel
Induction of potent humoral an ...... ors with deleted serpin genes.
@ast
Induction of potent humoral an ...... ors with deleted serpin genes.
@en
P2093
P2860
P1433
P1476
Induction of potent humoral an ...... ors with deleted serpin genes.
@en
P2093
Fatema A Legrand
Kenneth S Chan
Leslie A Jones
Paulo H Verardi
Tilahun D Yilma
P2860
P304
P356
10.1128/JVI.78.6.2770-2779.2004
P577
2004-03-01T00:00:00Z